Menu Search
Equities

John Wiley & Sons Inc

2F7:DEU

John Wiley & Sons Inc

Actions
  • Price (EUR)33.60
  • Today's Change0.20 / 0.60%
  • Shares traded0.00
  • 1 Year change-31.98%
  • Beta--
Data delayed at least 15 minutes, as of May 31 2023 20:43 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

John Wiley & Sons, Inc. is engaged in scientific research and career-connected education. The Company' segments include Research Publishing & Platforms, Academic & Professional Learning, and Education Services. The Research Publishing & Platforms segment provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. The Academic & Professional Learning segment provides education publishing and professional learning content and courseware, training, and learning services, to students, professionals, and corporations. The Education Services segment provides university services (online program management (OPM) services) for academic institutions and talent development services, including placement and training for professionals and businesses. The Company has operations in Russia consisting primarily of technology development resources.

  • Revenue in USD (TTM)2.04bn
  • Net income in USD-7.97m
  • Incorporated1904
  • Employees9.50k
  • Location
    John Wiley & Sons Inc111 River StHOBOKEN 07030-5773United StatesUSA
  • Phone+1 (201) 748-6000
  • Fax+1 (201) 748-6088
  • Websitehttps://www.wiley.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.